Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$437,678,995
+$12,082,669 QoQ
Shares Held
2,792,745
+0.2% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#10
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $34,817,743,578 across 17 Drug Manufacturers - General names. NVS ranks #9 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,796,866 | $10,551,225,859 | |
| 2 | JNJ |
Johnson & Johnson
|
28,792,064 | $7,312,320,489 | |
| 3 | ABBV |
AbbVie Inc.
|
20,558,447 | $5,173,327,597 | |
| 4 | MRK |
Merck & Co., Inc.
|
26,275,718 | $3,376,429,761 | |
| 5 | AMGN |
Amgen Inc
|
6,200,994 | $2,245,503,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
13,828,010 | $1,747,030,778 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,918,384 | $1,435,797,281 | |
| 8 | PFE |
Pfizer Inc
|
59,084,573 | $1,422,756,513 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $437,678,995 | 2,792,745 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $425,596,326 | 2,786,228 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $324,157,323 | 2,351,181 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $304,106,923 | 2,371,389 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $266,562,763 | 2,202,816 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $243,057,725 | 2,180,281 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $207,522,429 | 2,132,591 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $199,298,487 | 1,732,729 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $219,227,008 | 2,059,243 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $208,056,169 | 2,150,896 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $216,093,166 | 2,140,172 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $220,766,982 | 2,167,357 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $225,038,986 | 2,230,096 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $233,362,600 | 2,536,550 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $229,860,891 | 2,533,740 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $199,687,617 | 2,627,123 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $233,961,625 | 2,767,794 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $249,472,195 | 2,842,988 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $271,880,638 | 3,108,273 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $266,161,021 | 3,254,598 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $325,437,840 | 3,566,833 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $327,093,748 | 3,826,553 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $361,619,777 | 3,829,501 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $337,568,370 | 3,881,881 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $328,407,394 | 3,760,103 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $296,990,340 | 3,602,066 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||